Hungary makes first-ever pledge to Gavi, the Vaccine Alliance with EUR 1 million commitment, joining a growing group of new donors to Gavi’s 2026–2030 funding cycle
The commitment reinforces Hungary’s leadership in global development and strategic partnership with Africa, aligned with Gavi’s mission to save lives, keep the world safe from infectious disease threats and deliver economic benefits through immunisation
Hungary’s pledge builds on European leadership following the AVMA launch in Paris and the Global Summit in Brussels, and reflects shared values of solidarity, health equity and child protection in fragile and under-served settings
Geneva, 4 November 2025 – Building on the critical momentum made through European leadership on global development and partnership with Africa, and cementing its contribution to global, continental and national health security, Hungary has pledged for the first time to Gavi, the Vaccine Alliance with a EUR 1 million commitment to the next strategic period from 2026 through 2030. The pledge is a recognition of the importance of solidarity between nations, and how Gavi’s mission aligns with Hungarian values on the protection of health of children and their families.
Hungary’s commitment of EUR 1 million means it joins a record number of new donors to Gavi’s efforts, and brings renewed momentum towards Gavi’s goal of achieving full funding to reach 500 million children and provide US$ 100 billion in economic benefits to partner countries over the next five years.
The commitment further builds on strong Team Europe cooperation in support of immunisation, health security and prosperity. In June 2024, France under President Emmanuel Macron hosted the launch of both the African Vaccine Manufacturing Accelerator (AVMA) and Gavi’s 2026–2030 Investment Opportunity, which culminated in the Global Summit: Health & Prosperity through Immunisation in Brussels in June 2025, co-hosted by the European Union and the Gates Foundation, which raised more than US$ 9 billion towards a target of US$ 11.9 billion.
“Hungary’s first-ever contribution to Gavi is a powerful signal of solidarity and shared responsibility in advancing global health,” said José Manuel Barroso, Chair of the Board of Gavi. “As we work to protect 500 million children through immunisation over the next five years, every new partnership strengthens our collective ability to deliver impact where it’s needed most. Hungary’s support reflects the growing momentum to invest in health security, equity and resilience, especially in the world’s most vulnerable communities.”
“More new donors are stepping up to support Gavi’s upcoming strategic period than at any time in our history,” said Dr Sania Nishtar, CEO of Gavi, the Vaccine Alliance. “We are grateful to Hungary for this pledge, which further underlines the broad support across the international community for Gavi’s mission to increase the equitable and sustainable use of vaccines.”
Gavi works in partnership and solidarity with lower-income nations around the world, with 80% of its resources being committed to African countries in its 2026–2030 strategic period (Gavi 6.0). Gavi’s next strategic period will also be guided by an ambitious reform initiative, Gavi Leap, aimed at furthering country ownership of immunisation and health security agendas. The initiative is built on principles of equal partnership – sovereignty and self-reliance through co-investment, and collaboration between agencies, led by countries, and driven by national development priorities. Gavi’s public-private partnership model pools demand, secures essential low-cost vaccines for countries, and supports long-term investments in health systems.
Hungary led the EU Council Presidency in 2024, with a focus on strengthening the humanitarian-development-peace nexus in fragile contexts – a role in which Gavi is proud to cement a first long-term partnership with Hungary.
Ensuring access to vaccines and primary health care services is a priority for Gavi in its next strategic period, including in highly fragile settings racked by conflict, vulnerability and deprivation. The strategic period will also see Gavi continue work to ensuring that communities have resilient access to essential preventive services that protect against over 20 life threatening diseases like malaria, diphtheria, polio and measles, as well as access to global stockpiles of cholera, mpox, yellow fever, Ebola and meningococcal vaccines when outbreaks hit.
MEDIA CONTACTS
Meg Sharafudeen
+41 79 711 55 54
msharafudeen@gavi.org
Cirũ Kariũki
+41 79 913 94 41
ckariuki@gavi.org
Collins Weru Mwai
+25 078 783 66 38
cmwai@gavi.org